Levi & Korsinsky notifies investors that it has commenced an investigation into STAAR Surgical Company (NASDAQ: STAA) concerning potential violations of the federal securities laws.
Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures. Following this news, shares of Staar fell over 24% on February 12, 2025. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
If you suffered a loss on your STAAR Surgical Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





